Lemborexant for Insomnia: Dual Orexin 5/10mg, 7-Hour Bedtime, 7–10-Day Review and Safety

　　1.Profile and Mechanism

　　Lemborexant competitively blocks orexin A/B binding to OX1R and OX2R,reducing central wake-promoting signaling to help initiate and maintain sleep.It is used for adult insomnia with difficulty falling asleep and/or staying asleep.It treats symptoms;it does not correct underlying stress,psychiatric,circadian,pain,or respiratory causes by itself.

　　2.Dosing

　　Adults:5mg once nightly,immediately before bed,with at least 7 hours remaining until planned awakening.

　　Increase to 10mg once nightly if effective control is incomplete and 5mg is tolerated;10mg is the maximum.

　　Take on an empty stomach or before meals when possible;taking with or soon after a meal may delay sleep onset.

　　Missed dose:skip for that night,resume the usual time next night;do not double or take during the day.

　　7–10-day review:record sleep-onset latency,number and length of night awakenings,return-to-sleep time,total sleep sense,and next-day alertness.If no improvement after 7–10 days or initial improvement followed by clear worsening,do not self-escalate;reassess cause and concomitant drugs.

　　3.How to Judge Response

　　Do not use“never insomniac again”as the goal.Use four observable items:

　　Faster sleep onset after lights off;

　　Fewer awakenings,especially mid/late-night wakefulness;

　　Quicker return to sleep after waking for urination,pain,or anxiety;

　　Better next-day function—less morning grogginess,steadier attention,mood,and safer driving/working performance.

　　Chronic insomnia should combine medication with sleep hygiene,stimulus control,and CBT-I rather than escalating pills alone.

　　4.Evaluate Underlying Causes

　　Persistent or recurrent insomnia needs cause work-up:

　　Psychosocial:stress,anxiety,depression,grief,shift-work changes;

　　Circadian:late-screen use,jet lag,advanced-phase elderly pattern;

　　Medical:pain,GERD,hyperthyroidism,restless legs,nocturia,menopausal flashes;

　　Respiratory:snoring,apnea,daytime sleepiness,obesity,thick neck;

　　Substances:caffeine,nicotine,alcohol,some antidepressants,bronchodilators,steroids,weight-loss stimulants;

　　Behavioral:phone in bed,excessive napping,weekend sleep shift.

　　If 7–10 days fails,or with low mood/suicidal ideation/severe anxiety/apnea/leg movements,refer to sleep,psychiatry,pulmonary,or neurology rather than increasing dose.

　　5.Safety Warnings

　　Common:somnolence,fatigue,headache,nightmares/abnormal dreams;somnolence rates vary by definition,roughly 7%–9%at 5mg and around 10%at 10mg in some datasets.

　　Next-day impairment:more likely at 10mg,with less than 7 hours in bed,or with other CNS depressants;caution driving and precision tasks.

　　Sleep paralysis:brief inability to move/speak at sleep transition;hypnagogic/hypnopompic hallucinations:vivid,sometimes frightening;cataplexy-like leg weakness is uncommon.

　　Complex sleep behaviors:sleepwalking,sleep-driving,cooking,eating,calling,sexual activity while not fully awake and no memory afterward—discontinue immediately and seek care.

　　Mood/behavior:new or worsening anxiety,agitation,depression,confusion,or suicidal thinking requires prompt medical contact.

　　Falls:higher in older adults,night-rising patients,and with sedatives/alcohol.

　　Respiratory:mild-moderate OSA/COPD data show limited added respiratory depression in selected studies,but moderate-severe disease,obesity hypoventilation,or prominent daytime sleepiness still needs specialist assessment.

　　6.Special Populations and Interactions

　　Contraindication:narcolepsy.

　　Hepatic:mild usually no change;moderate Child-Pugh B max 5mg;severe not recommended.

　　Renal:mild/moderate/severe usually no renal-only dose change,but elderly and polypharmacy need overall review.

　　Elderly≥65:titrate cautiously;>5mg increases fall and next-day sedation risk,not automatic 10mg.

　　Pregnancy,lactation,under 18:insufficient safety data;avoid routine use.

　　CYP3A:avoid strong/moderate inhibitors;with weak inhibitors max 5mg;avoid strong/moderate inducers because efficacy may fall.

　　CNS depressants/alcohol:benzodiazepines,opioids,tricyclics,some sedating antidepressants,and alcohol increase sedation,respiratory depression,and complex behaviors;do not combine with other hypnotics routinely,and avoid alcohol.